Trade

with

Coronado Biosciences Inc
(NASDAQ: CNDO)
AdChoices
=
1.83
0.00
0.00%
After Hours :
-
-
-

Open

1.80

Previous Close

1.83

Volume (Avg)

87.08k (200.52k)

Day's Range

1.80-1.94

52Wk Range

1.25-3.31

Market Cap.

81.09M

Dividend Rate ( Yield )

-

Beta

1.56

Shares Outstanding

44.31M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 0

    • Net Income

    • -37.16M

    • Market Cap.

    • 81.09M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.56

    • Forward P/E

    • -

    • Price/Sales

    • -

    • Price/Book Value

    • 1.12

    • Price/Cash flow

    • -2.64

      • EBITDA

      • -35.22M

      • Return on Capital %

      • -37.22

      • Return on Equity %

      • -49.14

      • Return on Assets %

      • -37.22

      • Book Value/Share

      • 1.63

      • Shares Outstanding

      • 44.31M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 1.70

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -0.83

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.19

              • 0.76

              • Current Ratio

              • 22.25

              • 2.92

              • Quick Ratio

              • 22.14

              • 2.35

              • Interest Coverage

              • -13.51

              • 38.02

              • Leverage Ratio

              • 1.26

              • 2.21

              • Book Value/Share

              • 1.63

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.17

                • 277.78

                • P/E Ratio 5-Year High

                • -15.00

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.48

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.35

                • Price/Book Value

                • 1.13

                • 8.50

                • Price/Cash Flow Ratio

                • -2.64

                • 50.25

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -49.14

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -37.22

                    (-)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -36.96

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • -

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -35.78M
                  Operating Margin
                  -
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -2.64
                  Ownership

                  Institutional Ownership

                  20.80%

                  Top 10 Institutions

                  16.23%

                  Mutual Fund Ownership

                  4.63%

                  Float

                  69.43%

                  5% / Insider Ownership

                  20.64%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    524,732

                  • 0.00

                  • 1.18

                  • Royce Micro-Cap Trust

                  •  

                    360,000

                  • 0.00

                  • 0.81

                  • Vanguard Extended Market Index Fund

                  •  

                    301,819

                  • 3.00

                  • 0.68

                  • Royce Value Trust

                  •  

                    170,000

                  • 0.00

                  • 0.38

                  • Advent-Claymore Enhanced Growth & Income

                  •  

                    145,000

                  • 0.00

                  • 0.33

                  • Vanguard Instl Total Stock Market Index

                  •  

                    139,507

                  • 0.00

                  • 0.31

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    94,005

                  • 0.00

                  • 0.21

                  • iShares Micro-Cap

                  •  

                    78,279

                  • 0.85

                  • 0.15

                  • Westcore Micro Cap Opportunity Fund

                  •  

                    63,943

                  • 0.00

                  • 0.14

                  • Global Trend Equity OP

                  •  

                    50,000

                  • 0.00

                  • 0.11

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Elliott Management Corp

                  •  

                    3,731,279

                  • 0.00%

                  • 8.42

                  • Vanguard Group, Inc.

                  •  

                    902,664

                  • -4.16%

                  • 2.04

                  • Royce & Associates, LLC

                  •  

                    530,000

                  • 0.00%

                  • 1.20

                  • Renaissance Technologies Corp

                  •  

                    523,900

                  • +33.51%

                  • 1.18

                  • Northern Trust Investments, N.A.

                  •  

                    283,436

                  • -13.33%

                  • 0.64

                  • Ancora Advisors LLC

                  •  

                    266,350

                  • +19.09%

                  • 0.60

                  • Goldman, Sachs & Co.

                  •  

                    232,202

                  • +84.07%

                  • 0.52

                  • Merrill Lynch & Co Inc

                  •  

                    209,837

                  • +92.86%

                  • 0.47

                  • Morgan Stanley & Co Inc

                  •  

                    186,185

                  • +637.31%

                  • 0.42

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  Small Growth

                  Coronado Biosciences Inc was incorporated on June 28, 2006. It is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. Its two main product candidates in clinical development ...moreare: TSO and CNDO-109. TSO, or CNDO-201, is a biologic comprising Trichuris suis ova, the microscopic eggs of the porcine whipworm. TSO is a biologic product candidate for the treatment of autoimmune diseases. CNDO-109 is a lysate that is disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components that activates donor Natural Killer cells. CTV-1 is a leukemic cell line re-classified as a T-cell acute lymphocytic leukemia, or ALL. The Company faces competition from many different sources, including commercial pharmaceutical and biotechnolog...morey enterprises, academic institutions, government agencies, and private and public research institutions. Government authorities in the United States, at the federal, state and local level, and other countries regulate, among other things, the research, development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing and export and import of products.lessless

                  Key People

                  Dr. Lindsay A. Rosenwald, M.D.

                  CEO/Chairman of the Board/Director/President

                  Dr. Eric K. Rowinsky,M.D.

                  Director/Vice Chairman of the Board

                  Dr. Lucy Lu, M.D.

                  CFO/Executive VP

                  Michael S. Weiss

                  Director/Executive VP, Divisional

                  Mr. David J. Barrett

                  Director

                  • Coronado Biosciences Inc

                  • 24 New England Executive Park

                  • Burlington, MA 01803

                  • USA.Map

                  • Phone: +1 781 652-4500

                  • Fax: +1 781 652-4545

                  • coronadobiosciences.com

                  Incorporated

                  2006

                  Employees

                  14

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: